OKYO Pharma Limited Company Profile
NASDAQ: OKYOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.39-0.039 (-2.73%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
OKYO Pharma at a glance
OKYO Pharma Limited (NASDAQ: OKYO) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2022. At a market capitalization of $74.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001849296, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- OKYO Pharma Limited
- Ticker
- NASDAQ: OKYO
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Guernsey
- IPO year
- 2022
- Market cap
- $74.00M
- SEC CIK
- 0001849296
Companies similar to OKYO Pharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRMLGreenland Mines Ltd. | 5.88 | +0.86% | $78.48M | vs OKYO |
| PTHSPelthos Therapeutics Inc. | 20.50 | -2.33% | $78.48M | vs OKYO |
| CSBRChampions Oncology Inc. | 4.98 | +2.05% | $69.31M | vs OKYO |
| CRDFCardiff Oncology Inc. | 1.06 | -2.75% | $82.46M | vs OKYO |
| CGTXCognition Therapeutics Inc. | 0.8952 | -4.42% | $85.13M | vs OKYO |
| ELOXEloxx Pharmaceuticals Inc. | 15.18 | +2.02% | $61.27M | vs OKYO |
| KLRSKalaris Therapeutics Inc. | 2.50 | -2.34% | $59.51M | vs OKYO |
| NMRANeumora Therapeutics Inc. | 0.4798 | +2.46% | $90.15M | vs OKYO |